脱发药的销售神话作者:郑敏芳编辑:松壑三生制药(1580.HK)10年前一笔5亿元的投资,如今已有近10倍的投资回报。这笔投资正是源自2015年三生制药所收购的蔓迪国际(下称“蔓迪”)。根据2025年11月A轮融资的投后估值,蔓迪身价达到58亿港元,较10年前收购价暴涨了近10倍。估值或许还有增长空间,日前三生制药正筹划分拆蔓迪至港股上市。蔓迪主攻脱发市场,核心产品系米诺地尔酊剂,收入已经突破10...
Source Link脱发药的销售神话作者:郑敏芳编辑:松壑三生制药(1580.HK)10年前一笔5亿元的投资,如今已有近10倍的投资回报。这笔投资正是源自2015年三生制药所收购的蔓迪国际(下称“蔓迪”)。根据2025年11月A轮融资的投后估值,蔓迪身价达到58亿港元,较10年前收购价暴涨了近10倍。估值或许还有增长空间,日前三生制药正筹划分拆蔓迪至港股上市。蔓迪主攻脱发市场,核心产品系米诺地尔酊剂,收入已经突破10...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.